Amygdala volume in depressed patients with bipolar disorder assessed using high resolution 3T MRI: The impact of medication
- 15 February 2010
- journal article
- research article
- Published by Elsevier BV in NeuroImage
- Vol. 49 (4), 2966-2976
- https://doi.org/10.1016/j.neuroimage.2009.11.025
Abstract
No abstract availableThis publication has 87 references indexed in Scilit:
- The genetics of bipolar disorderNeuroscience, 2009
- Bipolar and major depressive disorder: Neuroimaging the developmental-degenerative divideNeuroscience & Biobehavioral Reviews, 2009
- Common genetic determinants of schizophrenia and bipolar disorder in Swedish families: a population-based studyThe Lancet, 2009
- Gene-wide analyses of genome-wide association data sets: evidence for multiple common risk alleles for schizophrenia and bipolar disorder and for overlap in genetic riskMolecular Psychiatry, 2008
- Combined lithium and valproate treatment delays disease onset, reduces neurological deficits and prolongs survival in an amyotrophic lateral sclerosis mouse modelNeuroscience, 2008
- Histone deacetylase inhibitors up-regulate astrocyte GDNF and BDNF gene transcription and protect dopaminergic neuronsInternational Journal of Neuropsychopharmacology, 2008
- Neuroanatomical Characterization of Child Offspring of Bipolar ParentsJournal of the American Academy of Child & Adolescent Psychiatry, 2008
- Amygdala Volume in Patients Receiving Chronic Corticosteroid TherapyBiological Psychiatry, 2008
- Neocortical Gray Matter Volume in First-Episode Schizophrenia and First-Episode Affective Psychosis: A Cross-Sectional and Longitudinal MRI StudyBiological Psychiatry, 2007
- Greater Cortical Gray Matter Density in Lithium-Treated Patients with Bipolar DisorderBiological Psychiatry, 2007